Immunology News: Newly Discovered Mechanism Explains How Pathogens Avoid the Immune System & more...

Fri, 26 Apr 2024 04:59:34 -0700

Please click here to view this in your browser.

Newly Discovered Mechanism Explains How Pathogens Avoid the Immune System

Pathogens enter the body in different ways, but once inside, our immune systems detect and eliminate the foreign invaders. In some cases, pathogens find a way to survive in our body, falling below the radar of our immune cells. Certain pathogens hide inside our ...

Aspirin Reduces Cancer Progression

Aspirin is an over-the-counter medication used to reduce swelling and relieve pain. It is a salicylate medication, which means it reduces the formation of prostaglandins, which are critical in the process of inflammation, and prevents the formation of platelets. In general, it is given to reduce fever and help ...

How a Common Antibiotic Ointment Could Help Fight Viruses

Antibiotics are used to fight bacterial infections, and unless there is a risk that a viral infection will lead to more problems, antibiotics are not often recommended for other illnesses. However, a new study has suggestd that a general antibiotic called neomycin could help prevent viral infections in the ...

Immunity from COVID Booster is Superior to Primary Series

Last fall, COVID-19 vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting one. Unfortunately, an expert called the booster vaccination rate "abysmal," and the Centers for Disease Control and Prevention has said that vaccination booster rates remain ...

Ozempic: the popular weight-loss drug's association with cancer

Ozempic is well-known for its popularity in mainstream media as a weight loss drug. However, it was (and still is) originally indicated to treat diabetes mellitus. Ozempic is part of a group of medications called glucagon-like peptide 1 receptor agonist (GLP1-RA for short.) There have been claims of associations ...

Autoantibodies Predict Multiple Sclerosis Years in Advance

Researchers have identified a biomarker that reveals who will develop multiple sclerosis (MS) years in advance. In work reported in Nature Medicine, scientists showed that one in ten people who eventually are diagnosed with MS generate a specific set of autoantibodies many years before any symptoms of MS arise ...

UPCOMING WEBINARS

Is It Anti-RNP or Anti-Sm/RNP?

Dr. Lisa K. Peterson, Ph.D., D(AMBLI) - Assoc. Prof. of Pathology (Clinical) at the University of Utah and Medical Director of Immunology, ARUP Laboratories

Antibodies against ribonucleoprotein (RNP) are an important serologic marker for mixed connective tissue disease (MCTD). RNP interacts with Smith (Sm) proteins to form the Sm/RNP complex. Antigens for detecting U1-RNP antibody may include purified extracts (Sm/RNP complex), recombinant proteins, synthetic peptides, or dominant epitopes of the three main proteins (RNPA, RNPC, and RNP68/RNP70) ...

MAY 07, 2024 8:00 AM PDT

Overcoming Challenges with AAA Aggregate Analysis Using a Novel SEC Column to Determine Critical Quality Attributes

Shilin Cheung, Ph.D. - Sr. Research Scientist, Phenomenex Inc

As the most widely used viral vector for gene therapies, Adeno-Associated Viruses (AAVs) present unique advantages, including their ability to enter both dividing and non-dividing cells, the absence of human viral illness, and minimal immune response triggers. However, the complexity and size of AAVs pose challenges for their analysis. Traditional approaches struggle with their larger ...

MAY 08, 2024 8:00 AM PDT

See More Webinars

SCIENTIFIC PRODUCTS

BECKMAN COULTER LIFE SCIENCES

Apostle MiniMax™ High Efficiency Isolation...

SANTA CRUZ BIOTECHNOLOGY

CD133 Double Nickase Plasmid (m2)

LEICA BIOSYSTEMS

Leica VT1000 S vibrating blade microtome

SARTORIUS

Microsart® e.motion Membrane Filters

INFORS HT